{
    "clinical_study": {
        "@rank": "50208", 
        "arm_group": [
            {
                "arm_group_label": "First 48 hours", 
                "description": "Patients in the first 48 hours of non ST-elevation acute coronary syndromes."
            }, 
            {
                "arm_group_label": "3 months after discharge", 
                "description": "Patients with 3 months after hospital discharge for non ST-elevation acute coronary syndromes."
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to compare the response to aspirin in the acute phase with the\n      late phase of an acute coronary syndrome."
        }, 
        "brief_title": "Residual Platelet Activity Despite Aspirin Utilization in Coronary Heart Disease", 
        "completion_date": {
            "#text": "April 2012", 
            "@type": "Actual"
        }, 
        "condition": [
            "Coronary Heart Disease", 
            "Non ST-elevation Acute Coronary Syndromes"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Coronary Artery Disease", 
                "Myocardial Ischemia", 
                "Coronary Disease", 
                "Heart Diseases", 
                "Acute Coronary Syndrome"
            ]
        }, 
        "detailed_description": {
            "textblock": "The purpose of this study is to compare, in the same population, the response to aspirin in\n      the initial phase (first 48 hours) with the late phase (after 3 months of discharge)of a non\n      ST elevation acute coronary syndrome (angina or acute myocardial infarction)."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Age \u2265 18 years\n\n          -  Confirmed diagnosis of acute coronary syndrome without ST segment elevation, in the\n             first 48 hours after the onset of the clinical symptoms\n\n          -  Regular use of aspirin for at least seven days.\n\n        Exclusion Criteria:\n\n          -  Previous use, in the last 7 days, of another antiplatelet agent than aspirin\n\n          -  Use of antivitamin K in the last 3 weeks\n\n          -  Hemoglobin < 10g/dL and / or hematocrit < 30% or > 50%, platelets count < 100.000/mm3\n             or > 500.000/mm3, creatinine clearance < 30 mL / minute\n\n          -  Killip class III or IV\n\n          -  Need for vasopressor or inotropic parenteral medication at inclusion in the study\n\n          -  Percutaneous coronary intervention within 30 days or CABG in the last 90 days prior\n             to study entry\n\n          -  Current malignancy\n\n          -  Hematologic diseases\n\n          -  Refusal to sign the inform consent form\n\n          -  Unable to attend the second visit (follow-up) for any reason except for death"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "70 patients diagnosed with non ST acute coronary syndrome (unstable angina and myocardial\n        infarction without ST elevation), with up to 48 hours of evolution from the onset of\n        symptoms."
            }
        }, 
        "enrollment": {
            "#text": "70", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "July 10, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01820429", 
            "org_study_id": "INCORPA"
        }, 
        "intervention_browse": {
            "mesh_term": "Aspirin"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Platelet aggregation", 
            "Aspirin"
        ], 
        "lastchanged_date": "March 25, 2013", 
        "link": {
            "url": "http://www.incor.usp.br"
        }, 
        "location": {
            "facility": {
                "address": {
                    "city": "S\u00e3o Paulo", 
                    "country": "Brazil", 
                    "zip": "05403900"
                }, 
                "name": "Instituto do Cora\u00e7\u00e3o (Heart Institute) - Clinical Hospitals, University of S\u00e3o Paulo Medical School"
            }
        }, 
        "location_countries": {
            "country": "Brazil"
        }, 
        "number_of_groups": "2", 
        "official_title": "Residual Platelet Activity Despite Aspirin Utilization in Patients With Non ST Elevation Acute Coronary Syndromes: Comparison Between the Acute and Chronic Phases", 
        "overall_official": {
            "affiliation": "Instituto do Cora\u00e7\u00e3o (Heart Institute) - Clinical Hospitals, University of S\u00e3o Paulo Medical School", 
            "last_name": "Jose C Nicolau, MD, PhD", 
            "role": "Study Chair"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Brazil: National Committee of Ethics in Research", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "February 2012", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "measure": "Compare platelet aggregation between the first 48 hours and 3 months after discharge.", 
            "safety_issue": "No", 
            "time_frame": "3 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01820429"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "Relation between platelet aggregability  and  the composite endpoint of death, myocardial infarction, unstable angina and need for revascularization or hospitalization at 3 months after discharge.", 
                "safety_issue": "No", 
                "time_frame": "3 months"
            }, 
            {
                "measure": "Relation between the atherosclerotic burden by coronary angiography with the platelet aggregation in the first 48 hours.", 
                "safety_issue": "No", 
                "time_frame": "48 hours"
            }, 
            {
                "measure": "Relation between C reactive protein and interleukin -6 with levels of platelet aggregation.", 
                "safety_issue": "No", 
                "time_frame": "first 48 hours and 3 months"
            }, 
            {
                "measure": "Relation between platelet aggregation and the presence or absence of selected polymorphisms.", 
                "safety_issue": "No", 
                "time_frame": "first 48 hours and 3 months"
            }, 
            {
                "description": "Cut point for age 65 y, for glycemia 125 mg/dL, for glycated hemoglobin 6%", 
                "measure": "Platelet aggregation in respect to age, gender, glucose at hospital arrival, glycated hemoglobin, statin, PPI, current smokers, ACE inhibitors, type of ACS presentation.", 
                "safety_issue": "No", 
                "time_frame": "first 48 hours and 3 months"
            }
        ], 
        "source": "University of Sao Paulo General Hospital", 
        "sponsors": {
            "collaborator": {
                "agency": "Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "University of Sao Paulo General Hospital", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "December 2009", 
        "study_design": "Observational Model: Cohort, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "March 2013"
    }
}